ZTS (Zoetis Inc) Penghasilan resik perusahaan

Steady demand for veterinary pharmaceuticals supports the upward trend, and Zoetis Inc. (ZTS) total profit confirms this momentum. The value of 2.62 characterizes this level of profitability. Business resilience is based on a broad portfolio of medications for livestock and cats. Growth is driven by a unique partnership with clinics and physician loyalty, which accelerates the rollout of new products.

Zoetis Inc. (ZTS) - Bathi resik saka 04.07.2022 nganti 30.10.2026

Rincian metrik komprehensif lan analitis Zoetis (ZTS)

- nilai saham lan prakiraan konsensus rega:

Rega bursa Zoetis Corporation|ZTS - Prakiraan konsensus analis

- indikator valuasi pasar bisnis:

Nilai pasar Zoetis Corporation|ZTS - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data ekuitas miturut neraca:

Rega Buku Saham Zoetis|ZTS - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku zoetis.com|ZTS - Aset Agregat Perusahaan

- informasi babagan utang lan solvabilitas:

Koefisien Total Utang marang Modal Zoetis Inc.|ZTS - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Zoetis Inc|ZTS - Gunggung utang perusahaan|Utang-utang marang aset resik Zoetis Corporation|ZTS - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Zoetis|Indikator likuiditas cepet zoetis.com

- indikator bathi lan kelipatan valuasi:

ZTS - Penghasilan resik

Pambiji fundamental:ZTS - Zoetis Corporation

A defensive portfolio is constructed by seeking assets with stable cash flows. This indicator compares GAAP standards with actual sales, recording daily net income to assess operational efficiency. For Zoetis Inc. (ZTS), the value of 2.62 confirms the monetization of its leadership in the veterinary vaccines sector. Market dominance in pharmaceuticals strengthens the issuer's financial stability. The upward trend in the firm's net profit signals the persistence of high investment potential.

Pesaing utama